Pharmaceutical, Biotech, and Healthcare Industry News
There is a little-known class of drugs that many people in the pharmaceutical industry don’t know about. It is a class of drugs that is gradually having a bigger impact on the pharmaceutical, biotech, and healthcare industries. What is it? Orphan drugs. You can be...
A constantly changing biotech sector can make looking for a new job somewhat dicey. Biotech jobs with seasoned companies offer enough variables on their own. Jobs at startups add more uncertainty to the mix. By definition, startups are new companies just getting into the game,...
Here at Pharma Diversity, we do more than just offer access to pharmaceutical job boards. We also do our part to promote diversity in the biotech and pharmaceutical industries. As such, we are happy to report that, even though biotech diversity is still lagging, it...
Healthcare is, by definition, a person-focused industry. After all, a healthcare worker’s job is to help people through some of the most important moments of their life, from birth to death, from illness and injury to recovery. It is, in other words, a universal endeavor,...
Applying for Pharmacy Jobs: Why Recruits Have the Edge The job market is a lot like the real estate market. Sometimes it favors sellers, other times it favors buyers. The sellers in the job market are candidates being actively recruited by employers. And right now,...
The United States Supreme Court ruled on Monday that Title VII of the Civil Rights Act of 1964, which makes it illegal for employers to discriminate because of a person’s sex, also covers a person’s sexual orientation and transgender status.
The Food and Drug Administration withdrew its emergency use authorizations the two antiviral drugs promoted by President Trump, despite concerns surrounding their effectiveness and safety.
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
The drug President Trump has often touted as a treatment for COVID-19, despite it being, as yet, unproven, is set to begin a Phase III clinical trial.
Executives from some of the world’s largest pharmaceutical and biotechnology companies met with President Trump to discuss the timeline of a coronavirus vaccine.
